Search
Sinobioway Addresses 'Brokerage Firm Naming' Controversy: Advocates for Scientific Rehabilitation of Hyaluronic Acid Amid Unfair Attacks, Supported by Two Key Industry Associations
2025-05-20 /
Read about 0 minute
Author：小编
Sinobioway has issued a response to the recent 'brokerage firm naming' incident, emphasizing its role as an industry leader in hyaluronic acid and its commitment to rectify the unscientific disparagement surrounding this substance. This stance has garnered support from two prominent industry associations: the China Association of Plastic and Aesthetic Surgery and the China Flavor and Fragrance Cosmetics Industry Association. The majority of industry players concur with the notion of returning to scientific and commercial integrity.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
